|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Z, Zhang Y, Cao R, Li L, Zhong K,
Chen Q and Xiao J: miR-5195-3p inhibits proliferation and invasion
of human bladder cancer cells by directly targeting oncogene KLF5.
Oncol Res. 25:1081–1087. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang
Y, Liu J, Liu W and Liu X: MicroRNA-101 inhibits the proliferation
and invasion of bladder cancer cells via targeting c-FOS. Mol Med
Rep. 14:2651–2656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Dai Q, Zeng F and Liu H: MALAT1
promotes the proliferation and metastasis of osteosarcoma cells by
activating the Rac1/JNK pathway via targeting MiR-509. Oncol Res.
Apr 27–2018.(Epub ahead of print). View Article : Google Scholar
|
|
7
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
Noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. 26:345–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Liu H, Yang H, Gao Y, Zhang G and
Hu J: The long noncoding RNA, TINCR, functions as a competing
endogenous RNA to regulate PDK1 expression by sponging miR-375 in
gastric cancer. Onco Targets Ther. 10:3353–3362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu S, Kong D, Chen Q, Ping Y and Pang D:
Oncogenic long noncoding RNA landscape in breast cancer. Mol
Cancer. 16:1292017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng Y, Yang C, Tong S, Ding Y, Deng W,
Song D and Xiao K: Genetic variation of long non-coding RNA TINCR
contribute to the susceptibility and progression of colorectal
cancer. Oncotarget. 8:33536–33543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Y, Qiu M, Chen Y, Wang J, Xia W, Mao Q,
Yang L, Li M, Jiang F, Xu L and Yin R: Long noncoding RNA, tissue
differentiation-inducing nonprotein coding RNA is upregulated and
promotes development of esophageal squamous cell carcinoma. Dis
Esophagus. 29:950–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Z, Liu Y, He A, Li J, Chen M, Zhan Y,
Lin J, Zhuang C, Liu L, Zhao G, et al: Theophylline controllable
RNAi-based genetic switches regulate expression of lncRNA TINCR and
malignant phenotypes in bladder cancer cells. Sci Rep. 6:307982016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo J, Li H and Zhang C: MicroRNA-7
inhibits the malignant phenotypes of nonsmall cell lung cancer
in vitro by targeting Pax6. Mol Med Rep. 12:5443–5448. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu K, Chen Z, Qin C and Song X: miR-7
inhibits colorectal cancer cell proliferation and induces apoptosis
by targeting XRCC2. Onco Targets Ther. 7:325–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok
MT, Wang H, Chen J, Ng SS, Chen M, et al: microRNA-7 is a novel
inhibitor of YY1 contributing to colorectal tumorigenesis.
Oncogene. 32:5078–5088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong S, Zheng Y, Jiang P, Liu R, Liu X
and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell
lung cancer A549 cells through targeting BCL-2. Int J Biol Sci.
7:805–814. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thiel A and Ristimäki A: Targeted therapy
in gastric cancer. APMIS. 123:365–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Latacz A, Russell JA, Ocłon E, Zubel-łojek
J and Pierzchała-Koziec K: mTOR pathway-novel modulator of
astrocyte activity. Folia Biol (Krakow). 63:95–105. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sathe A and Nawroth R: Targeting the
PI3K/AKT/mTOR pathway in bladder cancer. Methods Mol Biol.
1655:335–350. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Magers MJ, Lopez-Beltran A, Montironi R,
Williamson SR, Kaimakliotis HZ and Cheng L: Staging of bladder
cancer. Histopathology. 74:112–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu L, Chen X, Zhang Y, Hu Y, Shen X and
Zhu W: Long non-coding RNA TUG1 promotes endometrial cancer
development via inhibiting miR-299 and miR-34a-5p. Oncotarget.
8:31386–31394. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hua F, Li CH, Chen XG and Liu XP: Long
noncoding RNA CCAT2 knockdown suppresses tumorous progression by
sponging miR-424 in epithelial ovarian cancer. Oncol Res.
26:241–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu TP, Liu XX, Xia R, Yin L, Kong R, Chen
WM, Huang MD and Shu YQ: SP1-induced upregulation of the long
noncoding RNA TINCR regulates cell proliferation and apoptosis by
affecting KLF2 mRNA stability in gastric cancer. Oncogene.
34:5648–5661. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang ZY, Lu YX, Chang YY, Chang YY, Zheng
L, Yuan L, Zhang F, Hu YH, Zhang WJ and Li XN: Loss of TINCR
expression promotes proliferation, metastasis through activating
EpCAM cleavage in colorectal cancer. Oncotarget. 7:22639–22649.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu N, Lian YJ, Dai X and Wang YJ: miR-7
increases cisplatin sensitivity of gastric cancer cells through
suppressing mTOR. Technol Cancer Res Treat. 16:1022–1030. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Glover AR, Zhao JT, Gill AJ, Weiss J,
Mugridge N, Kim E, Feeney AL, Ip JC, Reid G, Clarke S, et al:
MicroRNA-7 as a tumor suppressor and novel therapeutic for
adrenocortical carcinoma. Oncotarget. 6:36675–36688. 2015.
View Article : Google Scholar : PubMed/NCBI
|
